Trieu, Young <br/><br/>
Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo.  [electronic resource] 

 -  Cancer research  May 2004 
 - 3271-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.can-03-3764  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Apoptosis--physiology<br/>COS Cells<br/>Cell Division--physiology<br/>Cell Line, Tumor<br/>Chlorocebus aethiops<br/>Female<br/>Gene Transfer Techniques<br/>Genetic Therapy--methods<br/>Hodgkin Disease--genetics<br/>Interleukin-13 Receptor alpha1 Subunit<br/>Mice<br/>Mice, SCID<br/>Phosphorylation<br/>Receptors, Interleukin--biosynthesis<br/>Receptors, Interleukin-13<br/>STAT6 Transcription Factor<br/>Solubility<br/>Trans-Activators--metabolism